The Influence of Growth Hormone on Tumour Necrosis Factor and Neutrophil Leukocyte Function in Sepsis

References

• Rom W N, Basset P, Fells G A, Nukiwa T, Trapnell B C, Crysal R G. Alveolar macrophages release an insulin-like growth factor I-type molecule. J Clin Invest 1988; 82: 1685–93
   PubMed Web of Science ®Google Scholar
• Solomkin J S, Jenkins M K, Nelson R D, Chenoweth D, Simmons R L. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 1981; 90: 319–27
   PubMed Web of Science ®Google Scholar
• Lanser M E, Mao P, Brown G, Coleman B, Siegel J H. Serummediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg 1985; 202: 111–8
   PubMed Web of Science ®Google Scholar
• Vespasiano M C, Lewandoski J R, Zimmerman J J. Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shock. Crit Care Med 1993; 21: 666–72
   PubMed Web of Science ®Google Scholar
• Røkke O, Revhaug A, Giercksky K E. Polymorphonuclear leucocyte activation after trauma: evidence for increased generation of oxygen free radicals in response to in vitro endotoxin stimulation. Acta Chir Scand 1989; 155: 233–9
   PubMedGoogle Scholar
• Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1: 355–7
   PubMed Web of Science ®Google Scholar
• Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17: 975–8
   PubMed Web of Science ®Google Scholar
• Tracey K J, Fong Y, Hesse D G, Manogue K R, Lee A T, Kuo G C, Lowry S F, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330: 662–4
   PubMed Web of Science ®Google Scholar
• Silva A T, Bayston K F, Cohen J. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock. J Infect Dis 1990; 162: 421–7
   PubMed Web of Science ®Google Scholar
• Zamir O, Hasselgren P O, Kunkel S L, Frederick J, Higashiguchi T, Fischer J E. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 1992; 127: 170–4
   PubMedGoogle Scholar
• Schmidt H, Rush B, Simonian G, Murphy T, Hsieh J, Condon M. Thalidomide inhibits TNF response and increases survival following endotoxin injection in rats. J Surg Res 1996; 63: 143–6
   PubMed Web of Science ®Google Scholar
• Neuner P, Klosner G, Schauer E, Pourmojib M, Macheiner W, Grunwald C. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 1994; 83: 262–7
   PubMed Web of Science ®Google Scholar
• Wilmore D W, Moylan J AJ, Bristow B F, Mason A DJ, Pruitt B AJ. Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 1974; 138: 875–84
   PubMedGoogle Scholar
• Voerman B J, Strack-van-Schijndel R J, de-Boer H, Groeneveld A B, Nauta J P, van-der-Veen E A, Thijs L G. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support. J Crit Care 1994; 9: 143–50
   PubMed Web of Science ®Google Scholar
• Mjaaland M, Unneberg K, Hotvedt R, Revhaug A. Nitrogen retention induced by growth hormone after gastrointestinal surgery in patients with epidural analgesia and total parenteral nutrition. Eur J Surg 1991; 157: 21–7
   PubMedGoogle Scholar
• Gore D C, Honeycutt D, Jahoor F, Wolfe R R, Herndon D N. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg 1991; 126: 38–43
   PubMedGoogle Scholar
• Nolten W E, Goldstein D, Lindstrom M, McKenna M V, Carlson I H, Trump D L. Effects of cytokines on the pituitaryadrenal axis in cancer patients. J Interferon Res 1993; 13: 349–57
   PubMedGoogle Scholar
• Rovensky J, Vigas M, Lokaj J, Cuncik P, Lukac P, Takac A. Effect of growth hormone on the metabolic activity of phagocytes of peripheral blood in pituitary dwarfs and acromegaly. Endocrinol Exp 1982; 16: 129–34
   PubMedGoogle Scholar
• Rovensky J, Ferencikova J, Vigas M, Lukac P. Effect of growth hormone on the activity of some lysosomal enzymes in neutrophilic polymorphonuclear leukocytes of hypopituitary dwarfs. Int J Tissue React 1985; 7: 153–9
   PubMedGoogle Scholar
• Fu Y K, Arkins S, Wang B S, Kelley K W. A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion. J Immun 1991; 146: 1602–8
   PubMed Web of Science ®Google Scholar
• Spadoni G L, Spagnoli A, Cianfarani S, Del-Principe D, Menichelli A, Di-Giulio S, Boscherini B. Enhancement by growth hormone of phorbol diester-stimulated respiratory burst in human polymorphonuclear leukocytes. Acta Endocrinol Copenh 1991; 124: 589–94
   PubMedGoogle Scholar
• Wiedermann C J, Niedermuhlbichler M, Geissler D, Beimpold H, Braunsteiner H. Priming of normal human neutrophils by recombinant human growth hormone. Br J Haematol 1991; 78: 19–22
   PubMed Web of Science ®Google Scholar
• Wiedermann C J, Niedermuhlbichler M, Beimpold H, Braunsteiner H. In vitro activation of neutrophils of the aged by recombinant human growth hormone. J Infect Dis 1991; 164: 1017–20
   PubMed Web of Science ®Google Scholar
• Warwick Davies J, Lowrie D B, Cole P J. Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2. J Immun 1995; 154: 1909–18
   PubMed Web of Science ®Google Scholar
• Edwards C K, Ghiasuddin S M, Schepper J M, Yunger L M, Kelley K W. A newly defined property of somatotropin: priming of macrophages for production of superoxide anion. Science 1988; 239: 769–71
   PubMed Web of Science ®Google Scholar
• Wiedermann C J, Reinisch N, Braunsteiner H. Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood 1993; 82: 954–60
   PubMed Web of Science ®Google Scholar
• Wiedermann C J, Reinisch N, Kahler C, Geisen F, Zilian U, Herold M, Braunsteiner H. In vivo activation of circulating monocytes by exogenous growth hormone in man. Brain Behav Immun 1992; 6: 387–93
   PubMed Web of Science ®Google Scholar
• Edwards C K, Lorence R M, Dunham D M, Arkins S, Yunger L M, Greager J A, Walter R J, Dantzer R, Kelley K W. Hypophysectomy inhibits the synthesis of tumor necrosis factor alpha by rat macrophages: partial restoration by exogenous growth hormone or interferon gamma. Endocrinology 1991; 128: 986–9
   Web of Science ®Google Scholar
• Kappel M, Hansen M B, Diamant M, Pedersen B K. In vitro effects of human growth hormone on the proliferative responses and cytokine production of blood mononuclear cells. Horm Metab Res 1994; 26: 612–4
   PubMed Web of Science ®Google Scholar
• Røkke O, Revhaug A, Østerud B, Giercksky K E. Increased plasma levels of endotoxin and corresponding changes in circulatory performance in a porcine sepsis model: the effect of antibiotic administration. Bacterial endotoxins. Pathophysiological effects, clinical significance and pharmacological control, J Levin, H R Buller, J W ten Cate, S JH van Deventer, A Sturk. Alan R. Liss, Inc., New York 1988; 247–62
   Google Scholar
• Bassoe C F, Laerum O D, Solberg C O, Haneberg B. Phagocytosis of bacteria by human leukocytes measured by flow cytometry. Proc Soc Exp Biol Med 1983; 174: 182–6
   PubMed Web of Science ®Google Scholar
• Sjursen H, Bjerknes R, Halstensen A, Naess A, Sornes S, Solberg C O. Flow cytometric assay for the measurement of serum opsonins to Neisseria meningitidis serogroup B, serotype 15. J Immunol Meth 1989; 116: 235–43
   PubMed Web of Science ®Google Scholar
• Wenisch C, Parschalk B, Hasenhundl M, Wiesinger E, Graninger W. Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections. Antimicrob Agents Chemother 1995; 39: 672–6
   PubMed Web of Science ®Google Scholar
• Hansen J B, Halvorsen D S, Haldorsen B C, Olsen R, Sjursen H, Kierulf P. Retention of phagocytic functions in cryopreserved human monocytes. J Leukoc Biol 1995; 57: 235–41
   PubMed Web of Science ®Google Scholar
• Bjerknes R, Bassoe C F. Phagocyte C3-mediated attachment and internalization: flow cytometric studies using a fluorescence quenching technique. Blut 1984; 49: 315–23
   PubMedGoogle Scholar
• Rothe G, Oser A, Valet G. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften 1988; 75: 354–5
   PubMed Web of Science ®Google Scholar
• Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immun Meth 1986; 95: 99–105
   PubMed Web of Science ®Google Scholar
• Zimmerman J J, Ringer T V. Inflammatory host responses in sepsis. Crit Care Clin 1992; 8: 163–89
   PubMed Web of Science ®Google Scholar
• Trautinger F, Hammerle A F, Poschl G, Micksche M. Respiratory burst capability of polymorphonuclear neutrophils and TNF-alpha serum levels in relationship to the development of septic syndrome in critically ill patients. J Leukoc Biol 1991; 49: 449–54
   PubMed Web of Science ®Google Scholar
• Petty H R, Francis J W, Boxer L A. Deficiency in immune complex uptake by chronic granulomatous disease neutrophils. J Cell Sci 1988; 90: 425–32
   PubMed Web of Science ®Google Scholar
• Solomkin J S, Bauman M P, Nelson R D, Simmons R L. Neutrophils dysfunction during the course of intra-abdominal infection. Ann Surg 1981; 194: 9–17
   PubMed Web of Science ®Google Scholar
• Yuge O, Nomura M, Mukaida K, Yoshida A, Kawamoto M, Morio M. Depression factors of neutrophil bactericidal activity with nitroblue tetrazolium reduction test in surgical patients. In Vivo 1988; 2: 195–9
   PubMedGoogle Scholar
• Becker J, Grasso R J. Suppression of yeast ingestion by dexamethasone in macrophage cultures: evidence for a steroid-induced phagocytosis inhibitory protein. Int J Immuno-pharmacol 1988; 10: 325–38
   PubMed Web of Science ®Google Scholar
• Fu Y K, Arkins S, Li Y M, Dantzer R, Kelley K W. Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone. Infect Immun 1994; 62: 1–8
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Zhang X J, Wolfe R R. Effect of tumor necrosis factor on substrate and amino acid kinetics in conscious dogs. Am J Physiol 1994; 266: E936–45
   Google Scholar
• Goodman M N. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991; 260: E727–30
   PubMed Web of Science ®Google Scholar
• Hesse D G, Tracey K J, Fong Y, Manogue K R, Palladino M A, Jr., Cerami A, Shires G T, Lowry S F. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166: 147–53
   PubMedGoogle Scholar
• Redl H, Schlag G, Adolf G R, Natmessnig B, Davies J. Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia. Infect Immun 1995; 63: 297–300
   PubMed Web of Science ®Google Scholar
• Stack A M, Saladino R A, Thompson C, Sattler F, Weiner D L, Parsonnet J, Nariuchi H, Siber G R, Fleisher G R. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit. Crit Care Med 1995; 23: 1512–8
   PubMed Web of Science ®Google Scholar
• Fisher C J, Jr, Opal S M, Dhainaut J F, Stephens S, Zimmerman J L, Nightingale P, Harris S J, Schein R M, Panacek E A, Vincent J L. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med 1993; 21: 318–27
   PubMed Web of Science ®Google Scholar
• Tracey K J, Beutler B, Lowry S F, Merryweather J, Wolpe S, Milsark I W, Hariri R J, Fahey T J, Zentella A, Albert J D. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470–4
   PubMed Web of Science ®Google Scholar
• Larrick J W, Graham D, Toy K, Lin L S, Senyk G, Fendly B M. Recombinant tumor necrosis factor causes activation of human granulocytes. Blood 1987; 69: 640–4
   PubMed Web of Science ®Google Scholar
• Shalaby M R, Palladino M A, Jr, Hirabayashi S E, Eessalu T E, Lewis G D, Shepard H M, Aggarwal B B. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukoc Biol 1987; 41: 196–204
   PubMed Web of Science ®Google Scholar
• Tsujimoto M, Yokota S, Vilcek J, Weissmann G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun 1986; 137: 1094–100
   PubMed Web of Science ®Google Scholar
• Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990; 172: 599–607
   PubMed Web of Science ®Google Scholar
• Lantz M, Bjornberg F, Olsson I, Richter J. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J Immun 1994; 152: 1362–9
   PubMed Web of Science ®Google Scholar
• Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, Adolf G. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 1989; 42: 270–5
   PubMed Web of Science ®Google Scholar